Ovarian Stimulation Single Injection Elonva- The OSSIE Study

Trial Profile

Ovarian Stimulation Single Injection Elonva- The OSSIE Study

Phase of Trial: Phase III

Latest Information Update: 23 Jun 2017

At a glance

  • Drugs Corifollitropin alfa (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Acronyms OSSIE
  • Most Recent Events

    • 19 Jun 2017 Status changed from recruiting to completed.
    • 08 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
    • 08 Aug 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top